Last update:
HIV & AIDS news
HIV & AIDS
HIV treatment and prevention in Zambian prisons may be model for prisons worldwide
A recent study performed in Zambia by University of Maryland School of Medicine's (UMSOM) Institute of Human Virology researchers found that high uptake of HIV preventative medicine, known as pre-exposure prophylaxis (PrEP), ...
1 hour ago
0
14
HIV trial shows viral suppression is not achieved through increased case management alone
Viral suppression of HIV by antiretroviral medications helps slow transmission of the disease and keep individuals living with it healthy, at times making viral loads so low they are undetectable even on blood tests. Sixty-five ...
Feb 9, 2023
0
3
Stigma and a lack of support limit HIV testing in Côte d'Ivoire
To improve HIV testing rates in the West African country of Côte d'Ivoire, community health workers need more training and support, researchers from the University of Washington School of Medicine in Seattle and the Institute ...
Feb 8, 2023
0
21
Resilience to HIV-related stigma may be key to ending the AIDS epidemic
Failing to address the psychological trauma experienced by many older people living with HIV/AIDS will make it difficult—if not impossible—to end the epidemic, according to a Rutgers University study.
Feb 7, 2023
0
3
African nations commit to ending AIDS in children by 2030
Twelve African countries on Wednesday spelt out plans for ending AIDS in children by 2030 through an array of HIV testing, treatment and prevention programs.
Feb 1, 2023
0
9
Scientists document two separate reservoirs of latent HIV in patients, delineating another challenge in creating a cure
When people living with HIV take antiviral therapy (ART), their viral loads are driven so low that a standard blood test cannot detect the virus. However, once ART is stopped, detectable HIV re-emerges with new cells getting ...
Jan 31, 2023
0
84
Study suggests side-effects and costs are biggest concerns for users of HIV pre-exposure prophylaxis
A new survey finds that men who would be potential users of HIV pre-exposure prophylaxis (PrEP) medication prefer long-acting injections over pills, but rank side effects and costs as the most important issues for them in ...
Jan 31, 2023
0
10
International AIDS relief program, at 20, looks to next steps
Saturday marks a major milestone in the global fight to eliminate the AIDS epidemic, as the U.S. President's Emergency Plan for AIDS Relief celebrates its 20th anniversary as the largest commitment by a country to combat ...
Jan 27, 2023
0
5
Tiny ion is crucial for HIV replication, say chemists
A study by chemists at the University of Chicago has uncovered a new key step in the process that HIV uses to replicate itself.
Jan 24, 2023
0
63
Scientists find potential cellular target for HIV therapies
Researchers at The Herbert Wertheim UF Scripps Institute for Biomedical Innovation & Technology have discovered a protein that appears to play a key role in helping HIV replicate in human immune cells, providing more clues ...
Jan 19, 2023
0
57
People with HIV may experience higher rates of inflammation and immune activity during pregnancy
People with HIV have a higher chance of having chronic systemic inflammation during pregnancy, according to a Rutgers study.
Jan 18, 2023
0
18
Experimental HIV vaccine regimen safe but ineffective, NIH study finds
An investigational HIV vaccine regimen tested among men who have sex with men (MSM) and transgender people was safe but did not provide protection against HIV acquisition, an independent data and safety monitoring board (DSMB) ...
Jan 18, 2023
0
4
Rapid cognitive decline uncommon in aging people with HIV on stable treatment, says study
With successful treatment, HIV has become a chronic health condition which can be managed with life-long care.
Jan 16, 2023
0
17
Researchers uncover how HIV reservoir cells resist elimination by human immune responses
Soon after infection, HIV-1 establishes a life-long presence by forming viral reservoirs in the body—cells that are infected with HIV but not actively producing new viruses. Antiretroviral therapy (ART) reduces HIV levels ...
Jan 10, 2023
0
32
Paving the way toward a cure? Study reports new insights into role of proteins in HIV latency
Understanding HIV latency at the molecular level is crucial for efforts to eliminate the viral scourge that causes AIDS. Latent infected cell reservoirs—where the human immunodeficiency virus (HIV) hides and persists in ...
Jan 10, 2023
0
54
Cognitive behavioral intervention ups antiretroviral therapy adherence in adolescents, young adults
The Adherence Connection for Counseling, Education, and Support (ACCESS) peer-led, mobile health cognitive behavioral antiretroviral therapy (ART) adherence intervention improves adherence to ART for adolescents and young ...
Jan 9, 2023
0
2
HIV remains a leading killer in Africa despite medical breakthroughs—how to eliminate it
About 38 million people around the world are living with HIV. About 70% of them live in Africa. This shows that there is no solution to the AIDS pandemic without a solution in Africa. In 2021, there were 1.5 million new cases ...
Jan 9, 2023
0
7
Women experiencing intimate partner violence three times more likely to contract HIV
Women that experience recent intimate partner violence (IPV) are three times more likely to contract HIV, according to a new study led by McGill University researchers. In regions like Sub-Saharan Africa, women face an intersecting ...
Jan 5, 2023
0
13
Epigenetic aging associated with aberrant neural oscillatory dynamics of visuospatial processing in those with HIV
A new research paper titled "Epigenetic aging is associated with aberrant neural oscillatory dynamics serving visuospatial processing in people with HIV" has been published in Aging.
Jan 5, 2023
0
3
